NSE ScannerMedical Devices & Supplies · Medical Distributors · NSE: QMSMEDI · data 2026-11-01
QMS Medical Allied Services Limited
In plain words
Price: 16.4% below its 52-week high of ₹216.79.
Delivery: 65.2% of traded shares were kept for delivery over the last 10 sessions, against 62.0% over the last 40.
Latest results: a net profit of ₹4 cr for the quarter ended Jun 2026 (-42.2% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹183 cr |
| Net profit (last 12 months) | ₹11 cr |
| Sales growth, 3 years (yearly) | 49.3% |
| Profit growth, 3 years (yearly) | 49.4% |
At a glance
Promoters 68.1% (unchanged in a year), pledged 0.0%, institutions 1.7%.
P/E 31.6, dividend yield 0.3%. Price relative to earnings and book value (low is cheaper, not better).
ROE 10.5%, ROCE 18.9%, operating margin 12.7%: how much profit it earns on the money it uses.
Debt/equity 0.71, Profit growth 49.4% and sales growth 49.3% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Profit grew 49.4% a year over 3 years.
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q1 FY27)
QMSMEDI Q1 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹56.87 crore, up 22.3% YoY.
Net profit was ₹3.65 crore, down 42.2% YoY.
Operating margin was 14.6% (12% a year ago).
EPS was ₹2.05, down 42.1% YoY.
QMSMEDI के Q1 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹56.87 करोड़; पिछले साल की तुलना में 22.3% की बढ़त।
शुद्ध मुनाफ़ा: ₹3.65 करोड़; पिछले साल की तुलना में 42.2% की गिरावट।
ऑपरेटिंग मार्जिन: 14.6% (एक साल पहले 12%)।
EPS: ₹2.05; पिछले साल की तुलना में 42.1% की गिरावट।
QMSMEDIના Q1 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹56.87 કરોડ; ગયા વર્ષની સરખામણીએ 22.3% વધારો.
ચોખ્ખો નફો: ₹3.65 કરોડ; ગયા વર્ષની સરખામણીએ 42.2% ઘટાડો.
ઓપરેટિંગ માર્જિન: 14.6% (એક વર્ષ પહેલાં 12%).
EPS: ₹2.05; ગયા વર્ષની સરખામણીએ 42.1% ઘટાડો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
5/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Too few delivery days to compare delivery % (0 of 10); shares delivered not comparable (0 of 12); 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Dividend ● Results
- 23 Sept 26Dividend Dividend ₹0.5 (ex-date) -0.1% next session
- 14 Aug 26Results Q1 FY27 results: profit −42.2% YoY +6.6% next session
- 14 Feb 26Results Q3 FY26 results: net profit ₹3.2 cr +5.0% next session
- 13 Aug 25Results Q1 FY26 results: net profit ₹6.3 cr -1.4% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Jun 2026 | ₹57 cr | ₹4 cr | -42.2% | 14.6% | 2.05 |
| Dec 2025 | ₹37 cr | ₹3 cr | — | 15.4% | 1.24 |
| Jun 2025 | ₹46 cr | ₹6 cr | — | 12.0% | 1.64 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Sept 2025 |
|---|---|---|---|---|
| Promoters | 68.11% | 68.11% | 68.11% | 68.11% |
| Foreign institutions (FII) | 0.41% | — | 0.00% | 0.01% |
| Domestic institutions (DII) | 1.30% | 1.59% | 1.59% | 1.60% |
| Mutual funds | — | — | 0.00% | 1.60% |
| Retail investors | 13.34% | 14.43% | 15.38% | 15.76% |
| Number of shareholders | 2,437 | 1,554 | 1,499 | 1,564 |
Common questions
What was QMS Medical Allied Services Limited's latest quarterly profit?
QMS Medical Allied Services Limited reported a net profit of ₹4 cr for the quarter ended Jun 2026 (-42.2% on the same quarter a year earlier), on revenue of ₹57 cr.
How much do promoters hold in QMS Medical Allied Services Limited?
Promoters held 68.11% of QMS Medical Allied Services Limited at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is QMS Medical Allied Services Limited debt-free?
Its latest reported debt-to-equity ratio is 0.71.
What is QMS Medical Allied Services Limited's P/E ratio?
About 31.6, based on the last 12 months' earnings and a price of ₹181.17 (data 2026-11-01).
What is the 52-week high and low of QMS Medical Allied Services Limited?
The 52-week high is ₹216.79 and the 52-week low is ₹98.05.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| QMS Medical Allied Services Limited | ₹181.17 | ₹350 cr | 31.6 | — | 10.5% | 18.9% | 0.71 | +66.3% |
| Entero Healthcare Solutions Limited | ₹1,575.2 | ₹6,850 cr | 54.7 | — | 6.7% | 11.6% | 0.4 | +42.8% |
| Vijaypd Ceutical Limited | ₹76.05 | ₹149 cr | 29.6 | 2.8 | 11.8% | 9.2% | 0.7 | +70.9% |
| Balaxi Pharmaceuticals Limited | ₹19.15 | ₹106 cr | — | — | 0.6% | — | 0.23 | -55.3% |
| Aakaar Medical Technologies Limited | ₹71 | ₹101 cr | 15.2 | 1.8 | 17.1% | 25.8% | 0.34 | -15.5% |
| Vivo Bio Tech Ltd. | ₹13.72 | ₹31 cr | — | — | -2% | 8.3% | 0.72 | -31.9% |
Compare QMSMEDI with ENTERO in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open QMSMEDI in NSE Scanner →